Incidence of malignancy after pediatric kidney transplantation: a single-center experience over the past three decades in Japan

Yujiro Aoki(Toho University), Ken Sakai(Japanese Society for Dialysis Therapy), Seiichiro Shishido(Toho University), Yuko Hamasaki(Toho University), Hiroshi Hataya(Japanese Society for Dialysis Therapy), Kenji Ishikura(Kitasato University), Hiroyuki Satoh(Tokyo Metropolitan Children's Medical Center), Masaki Muramatsu(Queen Mary University of London), Ryoko Harada(Tokyo Metropolitan Children's Medical Center), Riku Hamada
Clinical and Experimental Nephrology
September 27, 2021
10.1007/s10157-021-02143-3
Cited by 6

Related Papers

Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial
|The Lancet|2014|450
IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome
|Pediatric Nephrology|2022|278
Creatinine-based equation to estimate the glomerular filtration rate in Japanese children and adolescents with chronic kidney disease
|Clinical and Experimental Nephrology|2013|267
Epidemiology of pediatric chronic kidney disease/kidney failure: learning from registries and cohort studies
|Pediatric Nephrology|2021|149
A multicenter randomized trial indicates initial prednisolone treatment for childhood nephrotic syndrome for two months is not inferior to six-month treatment
|Kidney International|2014|135